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Crystal Structure of the Cowpox Virus-Encoded NKG2D Ligand
OMCP
Eric Lazear, Lance W. Peterson,* Chris A. Nelson, Daved H. Fremont
Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, Missouri, USA
The NKG2D receptor is expressed on the surface of NK, T, andmacrophage lineage cells and plays an important role in antiviral
and antitumor immunity. To evade NKG2D recognition, herpesviruses block the expression of NKG2D ligands on the surface of
infected cells using a diverse repertoire of sabotage methods. Cowpox andmonkeypox viruses have taken an alternate approach
by encoding a soluble NKG2D ligand, the orthopoxvirus major histocompatibility complex (MHC) class I-like protein (OMCP),
which can block NKG2D-mediated cytotoxicity. This approach has the advantage of targeting a single conserved receptor instead
of numerous host ligands that exhibit significant sequence diversity. Here, we show that OMCP binds the NKG2D homodimer as
a monomer and competitively blocks host ligand engagement. We have also determined the 2.25-Å-resolution crystal structure
of OMCP from the cowpox virus Brighton Red strain, revealing a truncatedMHC class I-like platform domain consisting of a
beta sheet flanked with two antiparallel alpha helices. OMCP is generally similar in structure to known host NKG2D ligands but
has notable variations in regions typically used to engage NKG2D. Additionally, the determinants responsible for the 14-fold-
higher affinity of OMCP for human than for murine NKG2Dwere mapped to a single loop in the NKG2D ligand-binding pocket.
The ability to detect and remove abnormal or infected cells is akey function of the immune system. Many receptors are used
to detect and respond to pathogens, and one of the most studied is
the natural killer group 2, member D receptor (NKG2D), a ho-
modimeric type II membrane protein found on NK cells, murine
macrophages, and subsets of T cells (1). NKG2D is an activating
receptor on NK cells and a costimulatory receptor on T cells (2–7).
Humans and mice are known to express 8 and 9 sequence-diverse
NKG2D ligands (NKG2DLs), respectively (8). Engagement of
NKG2D by ligands presented on the surface of target cells initiates
a signaling cascade mediated by either of the membrane adaptor
proteins DAP10 and DAP12 that leads to release of cytolytic fac-
tors such as perforin and granzymes. Since cytolysis is potentially
damaging to host tissues, expression of NKG2DLs is tightly regu-
lated at both the transcriptional and posttranscriptional levels (9–
11). This limits NKG2DL expression on the cell surface of normal
cells. However, cellular stress induces the cell surface display of
NKG2DLs, which target the abnormal cell for elimination by
NKG2D-bearing lymphocytes (12, 13).
The importance of NKG2D surveillance in cancer immunity is
well established. Tumor cells expressing high levels of NKG2DLs
are more susceptible to immune clearance, and NKG2DLs have
been implicated in immunoediting of tumor cells (14, 15). To
avoid recognition by NKG2D-bearing cells, some human cancer
cells shed soluble NKG2DLs from their surface, preventing
NKG2D-mediated recognition and elimination (16–20).
Infection with many viruses induces the surface expression of
NKG2DLs (21–26). Therefore, NKG2D surveillance is a frequent
target of viral immune evasion strategies, with many viruses tar-
geting the cell surface display of NKG2DLs. Herpesviruses encode
multiple microRNAs (miRNAs) and proteins that target the ex-
pression and cell surface presentation of specific NKG2DLs (27–
32). However, the considerable sequence divergence and large
number of NKG2DLs limit the effectiveness of this strategy. In-
deed, no viral protein or miRNA that can broadly target all
NKG2DLs has been identified (8). For example, human cytomeg-
alovirus (HCMV) expresses UL16 and UL142, which both sabo-
tage NKG2DL surface expression. UL16 binds the human ligands
ULBP1 to -3, ULBP6, and MICB and retains them intracellularly
(9, 26, 33–38). However, despite binding MICB, UL16 does not
bind the closely related ligand MICA. To compensate for this,
UL142 can bind to MICA and retain it in the Golgi complex (39).
Even this strategy is incomplete, because the MICA gene is ex-
tremely polymorphic and UL142 does not recognize all MICA
alleles (39–41). Similarly, murine cytomegalovirus (MCMV) en-
codes four proteins that retain murine NKG2DLs inside the in-
fected cell. H60 is retained by m155; MULT1 is retained by m145;
MULT1, RAE-1ε, and H60 are retained by m138; and members of
the RAE-1 family are retained by m152 (27–30, 42–44). As with
UL142 recognition of MICA polymorphisms, some RAE-1 iso-
forms are more resistant to m152-induced retention (43). The
large number of host NKG2DLs and viral NKG2DL-evasion pro-
teins are thought to be a result of a continual cycle of evolution
and adaptation between virus and host (45).
In addition to its protective role against herpesviruses, NKG2D
is known to play an important role in the protection of mice from
ectromelia virus, suggesting that NKG2D may also contribute to
immunity to other poxviruses (46, 47). In support of this idea,
Campbell et al. discovered a protein termed OMCP, uniquely en-
coded by cowpox and monkeypox viruses (CPXV and MPXV,
respectively), which directly binds to the ectodomain of NKG2D
(48). OMCP from the Brighton Red strain (CPXV018; GenBank
sequence accession no. NP_619807) is a 171-residue protein that
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is abundantly secreted from infected cells and can block NKG2D-
mediated target cell killing by NK cells in vitro (48). While other
viral immune evasion strategies target the NKG2DLs, OMCP is
the first viral protein shown to directly target NKG2D. This strat-
egy has a significant advantage over targeting the NKG2DLs be-
cause while there are many NKG2DLs, the NKG2D receptor itself
is monomorphic and is highly conserved across mammals.
While NKG2DLs are divergent in sequence, they are conver-
gent in structure (49–53). The ectodomain of all known
NKG2DLs contains a major histocompatibility complex class I-
like (MHCI-like) platform domain composed of an antiparallel
beta sheet flanked by two antiparallel alpha helices. This conserved
structure allows the sequence-diverse NKG2DLs to interact with
the NKG2D receptor using a conserved binding interface (54).
Because OMCP is a viral antagonist of NKG2D, we tested whether
OMCP efficiently competes for NKG2D binding with host
NKG2DLs and show that OMCP is the strongest competitor for
NKG2D binding. Since OMCP, like NKG2DLs, binds directly
to NKG2D, we sought to solve the structure of OMCP to deter-
mine whether it made use of a similar overall structure. Here, we
describe the 2.25-Å-resolution structure of OMCP from the
Brighton Red strain of CPXV (OMCPBR) and show that it adopts
a truncated MHCI-like fold related to but distinct from those of
other structurally defined NKG2DLs. Evaluation of OMCP bind-
ing to NKG2D loop swap mutants, together with the competition
of OMCP with host NKG2DLs for NKG2D binding, strongly sug-
gests that OMCP binds the same groove of NKG2D used to rec-
ognize host NKG2DLs.
MATERIALS AND METHODS
Cloning, expression, and purification of OMCPBR. The untagged, ma-
ture OMCPBR coding sequence (lacking its 19-residue N-terminal signal
sequence) was amplified from genomic DNA and inserted between the
XhoI and NdeI sites of the bacterial expression vector pET-21a. Recom-
binant protein was recovered as inclusion bodies and refolded as previ-
ously described (55). Refolded protein was purified by size exclusion
chromatography on a Superdex 75 column (16/60; Amersham Biosci-
ences) and eluted as a single monodisperse peak. Protein was further
purified by hydrophobic interaction chromatography using a HiTrap
Phenyl HP column (GE Healthcare Life Sciences). Fractions containing
pure OMCP, verified by SDS-PAGE, were pooled, buffer exchanged to 25
mM HEPES (pH 7.4), and stored at 4°C. Inclusion bodies of selenome-
thionine-derivative OMCP (SeMet-OMCP) were refolded and purified
identically to the native protein.
Protein expression and purification ofNKG2DLs andNKG2Ds.Re-
combinant proteins for the ectodomains of MULT1, H60-birA, RAE-1ε,
RAE-1ε-birA, mNKG2D-birA, mNKhL2-birA, mNKhL3-birA, and
mNKHL23-birA were expressed in bacteria, recovered as inclusion
bodies, and refolded as previously described (55). Briefly, inclusion bodies
were denatured in 6 M guanidine-HCl and refolded against 400 mM
arginine, 100 mM Trizma, 2 mM EDTA, 5/0.5 mM reduced/oxidized
glutathione, and 0.2 mM phenylmethylsulfonyl fluoride (PMSF). Re-
folded protein was purified by size exclusion chromatography on a Super-
dex 75 column (16/60; Amersham Biosciences). Recombinant hNKG2D-
birA was prepared as described above with an additional purification step
over a Q-Sepharose column (Pharmacia) by gradient elution in 30 mM
Tris-HCl (pH 8.5), 0 to 500 mM NaCl. Purified hNKG2D-birA eluted
from the column at150 mM NaCl.
Crystallization, data collection, and processing. Native protein crys-
tals were grown by hanging drop vapor diffusion at 20°C from a mixture
of 0.5 l OMCP protein solution at 30 mg/ml in 25 mM HEPES, pH 7.4,
with well solution containing 0.9 M ammonium phosphate, pH 5.5. Crys-
tals were cryoprotected with well solution containing 15% ethylene glycol
and 1.5 M sodium malonate before being flash cooled directly in a liquid
nitrogen bath. SeMet-OMCP crystals were obtained similarly, with a well
solution containing 0.75 M ammonium phosphate (pH 5.1), 10 mM tri-
methylamine HCl, and 100 mM CaCl2 and flash cooled with cryopro-
tectant containing 333 mM ammonium phosphate (pH 5.1) and 2.8 M
sodium malonate (pH 5.5). Diffraction data were collected at the Ad-
vanced Light Source synchrotron (beamline 4.2.2). Native OMCP crystal
diffraction data were collected at a single wavelength of 0.9790 Å, while
SeMet-OMCP crystal diffraction was collected at wavelengths of 0.9792 Å
and 0.9641 Å (Table 1). Data processing with HKL2000 showed that the
crystals belonged to the primitive hexagonal space group P3221 (space
group 154) with unit cell dimensions of a b 105.14 Å and c 108.61
Å (56). These crystals have a solvent content of 62% with three OMCP
monomers in the asymmetric unit.
Model building and refinement. An initial phase solution was ob-
tained by multiwavelength anomalous dispersion (MAD) through the
autoSHARP server using both wavelengths of SeMet-OMCP diffraction
data (59). This initial model was used to provide a solution for the higher-
resolution native data set by molecular replacement through Phenix
AutoMR (57). Subsequent use of Phenix AutoBuild produced a much-
improved model, suitable for manual building. Reiterative refinement
and manual rebuilding were performed using phenix.refine and Coot,
respectively (57, 60). Both 2Fo-Fc and Fo-Fc maps were used for manual
building and to place solvent molecules. The final model yielded an Rfree
of 25.1 and an Rwork of 21.4 with 6% of all reflections set aside for free R
factor cross-validation. Additional refinement statistics are summarized
in Table 1. The final model contains residues His1 to Arg149 (mature
protein numbering, after signal sequence removal), with an additional
N-terminal glycine included in all copies as part of the bacterial expression
construct (Gly0). No density was observed for the last three C-terminal
residues (Asn150-Thr151-Gly152). Molecular images were produced us-
ing the program PyMOL (61).
MALS. Multiple-angle light scattering (MALS) experiments with
OMCP and OMCP/hNKG2D were performed as previously described
(62). Briefly, 100g (1 mg/ml) of OMCP or OMCP/hNKG2D was loaded
into a gel filtration column in series with a Dawn Helios II multiangle light
scattering detector (Wyatt), Optilab rEX (Wyatt), differential refractive
index detector, and photodiode array detector 996 (Waters). The data
were analyzed with the Astra V macromolecular characterization software
(Wyatt).
Surface plasmon resonance (SPR). A Biacore T100 instrument (GE
Health Sciences) was used to assess the competition between OMCP/
NKG2DLs and to determine the kinetics of OMCP interaction with
mNKG2D/hNKG2D loop swap mutants. All experiments were carried
out at a flow rate of 50l/min, 25°C, and in running buffer containing 10
mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% Triton X-100.
CM5 chips with immobilized neutravidin were made as previously de-
scribed (63).
For competition experiments, 10 nM mNKG2D was preincubated
with a titration of concentrations of OMCP, RAE-1ε, or MULT1. The
concentration of the three ligands was titrated in 2-fold dilutions from
1.25 to 40 nM. As a negative control for nonspecific inhibition, 10 nM
mNKG2D was also preincubated with 80 nM m144, an MHCI-like pro-
tein encoded by MCMV that does not bind NKG2D (Protein Data Bank
[PDB] code 1PQZ). The maximum binding response for mNKG2D at
each concentration was normalized to the mNKG2D binding seen with
m144 and then averaged across three separate experiments.
To assess the binding kinetics of the mNKG2D/hNKG2D loop swap
mutants, each loop swap mutant was site specifically biotinylated and
immobilized on a neutravidin-CM5 chip. OMCP was then injected across
different flow cells containing the respective loop swap mutants. Curves
were fitted with a 1:1 binding model. SPR experiments with the mNKhL2
and mNKhL23 variants indicate apparent mass transport limitations,
and therefore, quantitative assessment of disassociation rates is poten-
tially unreliable.
Structure of OMCP
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Atomic coordinate accession number. The atomic coordinates (ac-
cession code 4FFE) have been deposited in the Protein Data Bank, Re-
search Collaboratory for Structural Bioinformatics (Rutgers University,
New Brunswick, NJ).
RESULTS
Competition ofOMCPwithhostNKG2DLs.OMCP is an immu-
nomodulatory protein expressed by CPXV and MPXV that di-
rectly binds to NKG2D (48). OMCP is highly secreted from in-
fected cells, and previous work has shown that OMCP can inhibit
the lysis of NKG2DL-expressing target cells by NK cells (48).
However, OMCP also binds to at least one other cellular receptor,
FcRL5, in addition to NKG2D (64). We therefore wanted to test
the ability of OMCP to compete with host NKG2DLs for NKG2D
binding in a cell-free system, excluding the possibility of other
receptors cooperating in this interaction.
OMCP binds to both the human and murine NKG2Ds with
affinities that are equivalent to or greater than those of all known
host NKG2DLs. The reported affinities for hNKG2D with human
NKG2DLs MICA, MICB, and ULBP3 are1M, while the affin-
ity of OMCP for hNKG2D is0.2 nM, an5,000-fold difference
(12, 51). In contrast, murine NKG2DLs bind mNKG2D with af-
finities ranging from 350 to 730 nM for RAE-1-, 20 to 80 nM for
RAE-1ε, and 6 to 20 nM for MULT1 and H60 (12, 63, 65, 66). Like
H60 and MULT1, OMCP has an affinity in the low-nanomolar
range (48, 65, 67). To stringently test the competition between
host NKG2DLs and OMCP, we used high-affinity murine
NKG2DLs.
The extracellular domains of birA-tagged H60 and RAE-1ε
were refolded from bacterial inclusion bodies. Their birA tags
were then site specifically biotinylated with birA ligase. H60 and
RAE-1ε were then immobilized on SPR chips coated with neutra-
vidin. To test the ability of OMCP to compete with surface-im-
mobilized NKG2DLs, a constant amount of the mNKG2D extra-
cellular domain was injected across the surface of the SPR chip
with increasing amounts of OMCP. As a positive control for
NKG2D binding competition, the extracellular domains of
RAE-1ε and MULT1 were also tested. As a negative control for
NKG2D binding competition, mNKG2D was also injected with an
80 nM concentration of an irrelevant protein, m144. Each injec-
tion contained 10 nM mNKG2D with a different concentration of
OMCP, MULT1, or RAE-1ε. The concentrations of NKG2L or
OMCP ranged from 1.25 nM to 40 nM in 2-fold increments
(Fig. 1).
As expected, MULT1 and RAE-1ε inhibited mNKG2D binding
to the surface-immobilized NKG2DLs. Between the two host li-
gands, MULT1 (50% inhibitory concentration [IC50] of 10 nM)
TABLE 1 Data collection, phasing, and refinement statistics for OMCP
Statisticd Native High remote Inflection
Data collection
Wavelength (Å) 0.9790 0.9641 0.9792
Resolution range (Å) 50–2.25 (2.33–2.25) 50–2.9 (3.00–2.90) 50–2.65 (2.74–2.65)
Space group P3221 P3221 P3221
Unit cell (Å) a b 105.17, c 108.66 a b 105.31, c 109.51 a b 105.35, c 108.48
Total reflections 251,334 168,403 162,234
Unique reflections 32,729 29,903 39,189
Redundancy 7.7 (5.3) 5.6 (5.1) 4.1 (3.5)
Completeness (%) 97.60 (88.8) 100.00 (100.0) 99.90 (99.5)
I/ (I)a 30.86 (2.73) 19.76 (3.51) 19.09 (2.53)
R-mergea 0.050 (0.486) 0.088 (0.496) 0.069 (0.504)
Phasing
Heavy atom sites 12
Phasing power (ano/iso) 1.1 1.4/2.0
FOM 0.56
Refinement
Resolution range (Å) 47.35–2.25 (2.31–2.25)
R-freeb 0.251 (0.387)
No. of atoms 3,959
Protein residues 450
Water molecules 164
RMS (bonds)b 0.002
RMS (angles)b 0.662
Ramachandran favored (%)c 98
Ramachandran outliers (%)c 0
Clash score, all atomsc 6.78
Average B-factor 50.2
Wilson B-factor 40.7
ML-est. coordinate error (Å)b 0.35
a As defined by HKL2000 (56).
b As defined by Phenix (57).
c As defined by MolProbity (58).
d Abbreviations: FOM, figure of merit; ML-est., maximum-likelihood estimated; RMS, root mean square.
Lazear et al.
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competed for NKG2D binding more effectively than did RAE-1ε
(IC50 of 20 nM), consistent with the higher affinity of MULT1.
OMCP also inhibited the binding of mNKG2D to surface-immo-
bilized NKG2DLs. OMCP and MULT1 inhibited mNKG2D with
very similar dose responses (IC50s of 8 nM and 10 nM, respec-
tively), demonstrating that OMCP can effectively compete for
mNKG2D with the highest-affinity host ligands in the absence of
other cellular receptors.
OMCP structure and oligomeric state. The structures of sev-
eral low-affinity host NKG2DLs have been solved, but no struc-
ture of a high-affinity NKG2DL has been reported. Additionally,
OMCP has the unique role of being a secreted viral decoy
NKG2DL. To better understand these unique properties, we de-
termined the structure of OMCP. OMCP protein from the Brigh-
ton Red strain of CPXV was obtained by refolding bacterial inclu-
sion bodies and crystallized. Diffraction data for native OMCP
crystals were collected to 2.25-Å resolution. The phase problem
was solved by multiple-wavelength anomalous dispersion (MAD)
methods using selenomethionine-labeled OMCP. OMCP crystal-
lized with three molecules in the asymmetric unit. Within the
asymmetric unit, chain X contained the lowest overall B factors,
and this molecule is displayed throughout this report (Fig. 2A).
Continuous electron density was observed in all regions, with the
exception of Gln108 in all three monomers, where the side chain
protrudes into a crystal solvent channel (Fig. 3A). The final model
has excellent geometry andR factors of 21.4% and 25.1% forRwork
and Rfree, respectively (Table 1).
The structure of OMCP consists of an MHCI-like 1/2 plat-
form domain (Fig. 2A). The helix of the OMCP1 domain (H1) is
continuous, while the helix of the 2 domain is broken into two
regions (H2a and H2b). The helices flank a six-stranded beta sheet
and together form the characteristic platform that defines MHC
proteins. Like other NKG2DLs (Fig. 2B), the alpha helices of
OMCP are close together and thus have no groove for binding
peptides or other ligands like antigen-presenting MHC platform
domains. OMCP contains one disulfide bond between S5 and
H2b, and this disulfide bond is conserved in most NKG2DLs (Fig.
2C). OMCP has two predicted N-linked glycosylation sites, one in
the S1-S2 loop and one in the S5-S6 loop (Fig. 2A and C). Both Asn
side chains are exposed to solvent and are likely to be glycosylated
when expressed in mammalian cells.
OMCP is significantly divergent in sequence from MHCI-like
proteins, with the Basic Local Alignment Search Tool (BLAST)
failing to align OMCP with any MHCI molecules (48). However,
three-dimensional (3D) superimposition analysis of OMCP using
the DALI server showed high similarity of OMCP with both clas-
sical and nonclassical MHCI platform domains (68). The top hit
was with the human neonatal FcR (3m17), where 136/150 OMCP
residues were aligned with 13% sequence identity and a root mean
square deviation (RMSD) of 2.7 Å. DALI identified all host
NKG2DLs as being related to OMCP, with MICB (2wy3) scoring
highest with statistics very similar to those of FcRn, aligning 136/
150 OMCP residues with 15% sequence identity and an RMSD
of 3.1.
OMCP formed a trimer in the asymmetric unit of the crystal
with a total buried surface area of 1,550 Å2 (Fig. 3A). The beta
sheet of one OMCP monomer formed the primary contact on one
side of the interface, with every beta strand but strand 4 interacting
with an adjacent OMCP monomer, burying 520 Å2 (interface 1 in
Fig. 3A). The other side of the interface consisted of strand 4 and
the loop between strand 4 and H1 and buried 510 Å2 (interface 2 in
Fig. 3A). The largely hydrophobic interface suggested that OMCP
might be secreted from infected cells as a trimer, although it is
important to point out that each monomer buries more surface
area in adjacent lattice contacts (856 Å2 and 737 Å2) than in trimer
contacts.
While multimeric OMCP could have a higher avidity for
NKG2D and thus compete more effectively with host NKG2DLs
for NKG2D, crystal lattice contacts provide limited support for
such a hypothesis. Therefore, we assessed the solution oligomeric
FIG 1 Competition with immobilized host NKG2DLs for mNKG2D binding. Murine NKG2D preincubated with each concentration of OMCP, MULT1, or
RAE-1ε was injected over an SPR chip containing immobilized biotinylated NKG2DLs (H60 or RAE-1ε). Binding was normalized to the amount of binding seen
with mNKG2D in the presence of an irrelevant protein. Each data point is the average of 3 experiments, with error bars indicating the standard errors.
Structure of OMCP
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state of OMCP, both alone and in complex with hNKG2D, using
multiple-angle light scattering (MALS) (Fig. 3B). Both OMCP
alone and OMCP/hNKG2D were resolved as monodisperse peaks,
indicating that only one species exists in solution. The experimen-
tal molecular masses for OMCP and OMCP/hNKG2D were 20.5
kDa and 51.6 kDa, respectively. These experimental molecular
masses are highly consistent with the calculated molecular masses
of monomeric OMCP (18.3 kDa) and with a 1:1 binding between
OMCP and a NKG2D homodimer (47.0 kDa). Native gel shifts
with OMCP titrations also support this binding stoichiometry
(data not shown). Together, these data demonstrate that OMCP is
a monomer in solution and that a single OMCP binds to a single
NKG2D homodimer.
Comparison of OMCP to host NKG2D ligands. The struc-
tures of four host NKG2DLs (MICA, MICB, ULBP3, and RAE-
1) have been determined, either unligated, bound to NKG2D, or
both, and OMCP differs prominently in several ways from all of
these NKG2DL structures (Fig. 2C) (49–53). The beta sheet of the
platform for OMCP has been truncated by two beta strands in the
2 domain, resulting in a six-stranded beta sheet (Fig. 2B). Devi-
ations from an eight-stranded beta sheet are rare for MHCI-like
molecules, with the 	 T-cell receptor ligand T22 and MCMV
protein m144 being notable examples (69–71). The alpha helices
for OMCP have also been truncated compared to those for other
NKG2DLs (Fig. 2). Host NKG2DLs have between 6 and 7 turns in
H1, 4 and 5 turns in H2a, and 6 and 8 turns in H2b. In contrast,
H1, H2a, and H2b of OMCP all have only 4 turns.
The position of the H2a helix relative to the beta sheet is also
unique in OMCP. The 2 helix of NKG2DLs is discontinuous,
with H2a and H2b hinged relative to each other. For host ligands,
this results in H2a being oriented away from the binding pocket of
NKG2D. As a result, H2a is not a part of the binding interface. The
angle between H2a and H2b in host NKG2DLs ranges from 86 to
98°. In contrast, the angle between H2a and H2b in OMCP is 108°.
This orientation makes the H2a and H2b helices flatter against the
beta sheet (Fig. 4A and B). The break between H2a and H2b of
OMCP hinges less than other NKG2DLs and instead translates
H2a closer to H1 (Fig. 4C and D). Thus, the position of H2a is
significantly differently in OMCP than in host NKG2DLs. The
combination of shorter helices, a translated H2a helix, and a larger
hinge angle between H2a and H2b in OMCP makes the putative
binding surface of OMCP for NKG2D overall more compact and
flatter than those of host NKG2DLs.
The structures of MICA and ULBP3 bound to human NKG2D
FIG 2 OMCP structure. (A) Ribbon diagram of CPXV OMCP. Secondary structure elements are noted, S for beta strands and H for helix. The 1/2 portions
of the platform domain are indicated in cyan and magenta, respectively. (B) Ribbon diagram of the 1/2 domain of MICA (PDB identifier 1HYR), with the 3
domain removed for clarity. Residues that contact NKG2D are colored yellow. (C) Structure alignment of OMCP with NKG2DLs. The mature sequences of
OMCPBR (CPXV-BR-018; GenBank accession number NP_619807; PDB identifier 4FFE) and OMCPMPX (MPXV-ZAR_1979_005-198; N3R; GenBank acces-
sion number AAY97396) are aligned with the ectodomain sequences of MICA (1HYR), MICB (1JE6), ULBP3 (1KCG), and RAE-1 (1JFM). Known NKG2D
contact residues for NKG2DLs are indicated in yellow. Asn residues likely to be glycosylated are noted by black boxes in panel C and as black side chains in panels
A and B.
Lazear et al.
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and of RAE-1 bound to murine NKG2D have been solved (50,
51, 53). Comparison of the three structures reveals a common
paradigm for interaction of NKG2DLs with NKG2D (Fig. 4D). All
three ligands primarily contact NKG2D using three elements: the
H1 helix, the H2b helix, and the loop between S1 and S2. An
alignment of OMCP secondary structure with the host NKG2DLs
reveals that OMCP diverges from host ligands in all three of these
NKG2D-contacting regions (Fig. 2C).
The S1-S2 loop of OMCP has been reduced to a two-residue
turn, likely preventing it from being close enough to interact with
NKG2D. Like the S1-S2 loop, the H1 and H2b helices of OMCP
have also been truncated. Based upon the alignments, the regions
of H1 and H2b in host ligands that make up the majority of
NKG2D contacts are missing from OMCP. Of the remaining re-
gions of H1 and H2b of OMCP, the only residue that appears to be
similar to a host NKG2DL contact residue is Asp132. An acidic
residue is found at the analogous position in the other NKG2DLs,
and this residue makes a contact with Tyr199 of NKG2D, one of
three critical binding residues of NKG2D (72). The high affinity of
OMCP for NKG2D, despite the loss of these regions, suggests that
OMCP has found a way to compensate. The reorientation of H2a
into a position that could contact NKG2D suggests that H2a may
have a role in interacting with NKG2D, unlike in host NKG2DLs
(Fig. 4D).
Mapping NKG2D regions required for high-affinity OMCP
binding. CPXV and MPXV are capable of infecting many species
and are generally thought to have small-rodent reservoirs (77).
Interestingly, despite the NKG2Ds being 70% identical, there is a
14-fold difference between the affinity of OMCP for human
NKG2D and that for murine NKG2D (0.20 
 0.06 nM versus
2.87 
 0.88 nM). The difference in OMCP affinity between the
two NKG2Ds is associated with the 2.3-fold-higher on-rate
(4.67  106 
 1.7  106 M1 s1 versus 10.6  106 
 1.7  106
M1 s1) and 6.4-fold-shorter half-life (5.8 
 1.4 min versus
0.9 
 0.28 min) of OMCP for hNKG2D. Previous experiments
with a different Biacore instrument gave very similar results, with
the only difference being a lower affinity of OMCP for mNKG2D
than that in our experiments (48). To understand the region of
NKG2D responsible for this difference in affinity, we designed
loop swap mutants between the two NKG2Ds.
While the binding site on NKG2D for OMCP is not known, the
similar structure of OMCP compared to those of other NKG2DLs
and the competition for binding suggest that OMCP binds to the
same surface on NKG2D as do host NKG2DLs. Therefore, we
analyzed the cocrystal structures of both hNKG2D and mNKG2D
bound to host NKG2DLs. NKG2DLs utilize a discrete surface of
NKG2D for binding (Fig. 5A). We therefore assessed all surface-
exposed side chains of NKG2D within 4 Å of NKG2DLs and com-
pared the sequences of hNKG2D and mNKG2D at those positions
(Fig. 5B to D). NKG2D primarily contacts NKG2DLs using three
loops (abbreviated L1, L2, and L3 here), and the sequences of two
of the loops differed between hNKG2D and mNKG2D. L2 (183 to
188, hNKG2D numbering) differs in both sequence and position,
while L3 (202 to 206) contains sequence differences but limited
structural differences (Fig. 5D). To test whether L2 and L3 play a
role in the affinity difference between NKG2Ds, the divergent
hNKG2D residues were substituted into an mNKG2D backbone
(Fig. 5C and D). We chose this combination by reasoning that a
reduction in the affinity of hNKG2D could be due to unpredicted
problems with the mutations, while a gain in affinity for the lower-
FIG 3 Assessment of OMCP oligomerization and NKG2D binding stoichio-
metry. (A) Packing of OMCP monomers within the crystal. OMCP crystallized
with three monomers related by 3-fold noncrystallographic symmetry (col-
ored cyan, magenta, and yellow) in the asymmetric unit of the P3221 space
group. For the displayed cyan monomer, trimer contacts bury 520 Å2 and 510
Å2 of surface area (interfaces labeled 1 and 2, respectively), while crystal sym-
metry mate contacts bury 856 Å2 and 737 Å2 (interface 3 and data not shown).
The location of Gln108, which lacked continuous electron density, is indicated
in the crystal solvent channel. (B) MALS molecular mass assessment of OMCP
alone and OMCP bound to hNKG2D. OMCP or OMCP/hNKG2D was first
passed through a gel filtration column before assessment by multiple-angle
light scattering, which allows for unambiguous mass determination for pro-
teins eluting as monodisperse peaks. Calc, calculated; Exp, experimental; amu,
atomic mass units.
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affinity mNKG2D would more rigorously test the role that these
loops play in OMCP binding.
The affinity of OMCP for hNKG2D, mNKG2D, and the three
loop swap mutants (designated mNKhL2 for L2, mNKhL3 for L3,
and mNKhL23 for substitutions in both loops) was determined
by SPR kinetic analysis. Each NKG2D contained a birA tag, which
allowed for site-specific biotinylation. OMCP was then injected
across each surface, and the on-rates and off-rates were compared
(Fig. 6). The binding of OMCP to mNKhL3 had affinity and ki-
netics equivalent to those of parental mNKG2D. However,
mNKhL2 and mNKhL23 displayed a low off-rate that is charac-
teristic of hNKG2D, with an on-rate that was not significantly
different from that of wild-type mNKG2D. Taken together, L3
does not appear to contribute significantly to the increase in
OMCP affinity, while L2 alone is able to increase the off-rate of the
OMCP-NKG2D interaction. Additionally, the effect of the loop
swap mutations on OMCP binding implicates the NKG2D-host
ligand-binding groove as the likely interface for OMCP binding.
DISCUSSION
In this study, we have demonstrated competitive binding of
OMCP to NKG2D, defined receptor-ligand binding stoichiome-
try, and determined the structure of OMCP to 2.25-Å resolution.
All known host NKG2DLs contain an MHCI-like platform do-
main, which is used to bind NKG2D (49–53). We show here that
OMCP also is composed of an MHCI-like platform domain, de-
spite low sequence identity with host NKG2DLs and other MHCI
molecules. While the types of interactions between individual host
NKG2DLs and NKG2D vary, the orientations of NKG2DL plat-
form domains with NKG2D are similar (74). The alpha helices of
NKG2DLs are oriented diagonally across the NKG2D binding
pocket, creating an asymmetric interaction with the symmetric
halves of the NKG2D homodimer (54). H1 and the S1-S2 loop of
host NKG2DLs contact one NKG2D monomer, while H2b con-
tacts the second NKG2D monomer. While OMCP is similar to
other NKG2DLs in overall organization of its platform domain, it
diverges in the specific elements used by NKG2DLs to bind
NKG2D.
Each contact site in host ligands (H1, H2b, and the S1-S2 loop)
has been shortened in OMCP. Additionally, the position of the
H2a helix is dramatically different than that of the H2a helix of
host NKG2DLs. The larger hinge angle between H2a and H2b
makes the H2a helix flatter relative to the beta sheet than that in
host NKG2DLs. This orients H2a into a position that could po-
tentially interact with NKG2D (Fig. 4D). These changes would
generate a unique surface to interact with NKG2D.
The most likely interaction orientation between OMCP and
NKG2D would be one similar to canonical NKG2DL-NKG2D
interactions. However, the truncations in OMCP in the regions
analogous to host ligand binding suggest that NKG2D engage-
ment may involve unique determinants. The diagonal orientation
of host NKG2DLs across the NKG2D binding groove is thought to
be forced by the hinge angle between H2a and H2b (54). The
flattening of the helices caused by the increased hinge angle be-
tween H2a and H2b in OMCP may allow OMCP to rotate to a
greater extent than that of other NKG2DLs. How much OMCP
may rotate is unclear, but a change in orientation could bring H2a
into contact with NKG2D. This would also potentially increase the
buried surface area of the OMCP-NKG2D interaction, which
could explain the high affinity of OMCP for NKG2D. Interest-
FIG 4 Comparison of H1, H2a, and H2b between OMCP and host NKG2DLs. (A) Side view of OMCP helices (red) overlaid with host NKG2DL helices (MICA
[1HYR[, MICB [1JE6], ULBP3 [1KCG], and RAE-1 [1JFM]) (gray). (B) Cartoon model showing the distinct helical angle for OMCP. (C) Top view of OMCP
helices (red) overlaid with host NKG2DL helices (gray). (D) Cartoon model with each half of the NKG2D dimer (cyan and green) shown in the same orientation
used to bind host NKG2DLs.
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ingly, Campbell et al. predicted that OMCP would adopt an
MHCI-like fold using hidden Markov and structure threading
methods (48). While modeling accurately predicted an OMCP
deletion located in the S7-S8 region of the beta sheet, the unique
helical elements were missed.
In this study, we have structurally characterized OMCP from
the Brighton Red strain of CPXV, which exhibits less than 60%
sequence identity to the highly conserved sequences (97% iden-
tity) found in 17 other CPXV and MPXV strains (73). Comparing
the mature sequences of OMCPBR and of OMCP encoded by
MPXV strain Zaire_1979, which also binds NKG2D, indicates that
14/59 sequence differences are localized to the helical regions (H1,
H2a, and H2b), with only 4 residues appreciably surface exposed
(Ile49Leu, Met115Ser, Thr118Ile, and Met135Ile). Of these four
substitutions, only Met135Ile is positioned at the structurally
aligned NKG2D binding interface observed for host NKG2DLs
(Fig. 2C). Thus, despite significant global sequence differences
between OMCPBR and other strains, the conservation of exposed
helical residues supports the hypothesis that these regions serve as
determinants for NKG2D binding.
The location of the N-linked glycosylation sites in OMCP also
supports the helices as the likely interface with NKG2D. Asn12 in
the S1-S2 loop is positioned under the platform and is distal from
the helices. This glycan site appears conserved in other OMCP
variants and in host NKG2DLs, with most having a glycan under
the platform domain and near S1. Unlike Asn12, Asn88 does not
appear to be conserved with other OMCP variants and NKG2DLs,
with the exception of MICA. Asn88 is oriented such that the gly-
can would be pointed to the side of the platform and away from
the proposed interaction site with NKG2D.
The interaction of host ligands with NKG2D is centered
on three key NKG2D residues: Tyr152, Met184, and Tyr199
(hNKG2D numbering). The two tyrosine residues are conserved
between human and murine NKG2Ds, but Met184 in human
NKG2D is changed to Ile200 in murine NKG2D. In addition, sub-
stitutions also exist in residues 181, 182, and 185, all of which are
contact residues for at least one NKG2DL. Furthermore, the po-
sition of these residues is slightly different between the NKG2D
homologues, with the backbone of murine NKG2D splaying far-
ther away from the binding groove. This region of NKG2D was
abbreviated as L2 in this report, and differences in OMCP affinity
between NKG2D homologues map to this region. Together, these
data suggest that OMCP makes use of the same core contact resi-
dues as do host ligands and that the differences in OMCP affinity
for NKG2D homologues likely are due to altered contacts in the L2
loop.
The difference in OMCP affinity for NKG2D homologues is
interesting in the context of zoonotic infection. While CPXV and
MPXV are thought to have small-rodent reservoirs, it is unclear if
the host NKG2D targeted by OMCP is a “mouse-like” or “human-
like” NKG2D (75). However, CPXV and MPXV do infect hu-
mans, and the incidence of infection with MPXV has risen since
the eradication of smallpox (75, 76). Therefore, it is important to
understand what the contribution of high-affinity OMCP-
hNKG2D binding would be to the pathogenesis of these viruses.
The effect of OMCP on human disease is unclear, because the two
poxviruses most commonly associated with human infections, va-
riola virus and vaccinia virus, do not encode an OMCP-like pro-
tein (48). The role of OMCP in modulating the immune response
has yet to be assessed in any in vivo pathogenesis models.
FIG 5 Generation of NKG2D loop swap mutants. (A) View into the hNKG2D ligand-binding groove. NKG2D contact residues for the three NKG2DLs are
colored according to frequency of use. Contacts in pale orange are used by a single NKG2DL, those in medium orange are used by two NKG2DLs, and those in
dark orange are used by all NKG2DLs. (B) Conservation of NKG2D contact residues between hNKG2D and mNKG2D. Identical residues are colored magenta,
and divergent residues are colored yellow. hNKG2D was used as the model. (C) Space-filling representation of NKG2D with L2 and L3 mutations colored green
and cyan, respectively. To facilitate comparison, the left monomer is from hNKG2D and the right monomer is from mNKG2D. (D) Overlays of L2 and L3
between human (dark green/cyan) and murine (light green/cyan) NKG2Ds. The side chains of divergent amino acids are shown. Sequence comparison of
mNKG2D and hNKG2D, with NKG2D ligand contact residues in orange and L2/L3 mutations noted by stars.
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A further complication for understanding the effect of OMCP
in pathogenesis arises because OMCP can bind FcRL5, which is
expressed by marginal zone B cells, as well as an unidentified bind-
ing partner expressed on macrophages (64). Because of the diver-
sity of receptors engaged by OMCP, further research will be re-
quired to identify the effect of OMCP binding on each receptor
individually and in combination with each other.
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